THURSDAY, Sept. 26, 2024 (HealthDay News) — “Body roundness” could be a better measure than BMI at predicting how excess weight might affect a person’s heart health, a new study finds. People who developed a high Body Roundness Index during a six-year period had a 163% increased risk of heartContinue Reading
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose. People with type 2 diabetes prescribed semaglutide (Ozempic, Wegovy) had a significantly lower riskContinue Reading
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster drugs Ozempic and Wegovy. While testifying before the Senate Committee on Health, Education, Labor and Pensions,Continue Reading
TUESDAY, Sept. 24, 2024 (HealthDay News) — Over 40 percent of U.S. adults are now obese, with rates roughly the same for men and women, new government data shows. Obesity rates fluctuated with age and fell as levels of education increased, said the report from the U.S. Centers for DiseaseContinue Reading
FRIDAY, Sept. 20, 2024 (HealthDay News) — Heavy-duty endurance exercise can cause body fat levels to drop without any accompanying weight loss, a new small-scale study indicates. A group of eleven middle-aged men who cycled 710 miles in seven days lost only about 1% of their total weight, because theyContinue Reading
WEDNESDAY, Sept. 17, 2024 (HealthDay News) — Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They’re in short supply, and often too expensive to afford without insurance coverage. Because of these barriers, many people are doing an end-run around their doctor’s office, reaching outContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, veterans with diabetes and what’s known as metabolic dysfunction-associated steatotic liverContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds. Ozempic and Wegovy (semaglutide) promoted the loss of 10% or more body weight in 61% of peopleContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Overweight or obese type 1 diabetics taking Mounjaro were able to reduce theContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows. In 2013, not one state had an adult obesity rate topping 35%, but 10Continue Reading